We are live on
!
Find out more
Lexicon Pharmaceuticals
LXRX
LXRX
108 hedge funds and large institutions have $214M invested in Lexicon Pharmaceuticals in 2020 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 38 increasing their positions, 23 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
65% more repeat investments, than reductions
Existing positions increased: 38 | Existing positions reduced: 23
63% more call options, than puts
Call options by funds: $258K | Put options by funds: $158K
2.17% more ownership
Funds ownership: 98.04% → 100.21% (+2.2%)
5% more capital invested
Capital invested by funds: $204M → $214M (+$9.42M)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
4% less funds holding
Funds holding: 113 → 108 (-5)
21% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 24
Holders
108
Holders Change
-5
Holders Change %
-4.42%
% of All Funds
2.21%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
19
Increased
38
Reduced
23
Closed
24
Calls
$258K
Puts
$158K
Net Calls
+$100K
Net Calls Change
+$52K
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$3.64M |
| 2 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$1.94M |
| 3 |
D.E. Shaw & Co
New York
|
+$1.58M |
| 4 |
Lazard Asset Management
New York
|
+$1.48M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$1.15M |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$2.55M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$1.41M |
| 3 |
Marshall Wace
London,
United Kingdom
|
-$801K |
| 4 |
HW
Hancock Whitney
Gulfport,
Mississippi
|
-$479K |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
-$467K |
